1. Research Framework

1.1. Research Objective

1.2. Product Overview

1.3. Market Segmentation

2.    Research Methodology

2.1. Qualitative Research

2.1.1.   Primary and Secondary Sources

2.2. Quantitative Research

2.2.1.   Primary and Secondary Sources

2.3. Breakdown of Primary Research Respondents

2.3.1.   Secondary Research

2.3.2.   Primary Research

2.4. Breakdown of Primary Research Respondents, By Industry Participants

2.5. Key Questionnaire asked during Primary Interviews

2.6. Key Primary Responses

2.7. Market Size Estimation

2.8. Assumption for the Study

2.9. Market Breakdown & Data Triangulation

3.    Executive Summary

4.    Global Cardiology Defibrillators Devices Sales Market – Industry Insights

4.1. DROC Analysis

4.1.1.   Growth Drivers

4.1.2.   Restraints

4.1.3.   Opportunity

4.1.4.   Challenges

4.2. Recent Developments / Technical Landscape

4.3. Regulatory Framework

4.4. Porter’s Five Forces Analysis

4.5. Value Chain Analysis

4.6. Strategic Outlook

5.    Global Cardiology Defibrillators Devices Sales Market Overview

5.1. Market Estimates & Forecast by Value, 2017-2027

5.1.1.   By Value (USD Million)

5.2. Market Share & Forecast

5.2.1.   By Product (Value, USD Million: 2017-2027)

5.2.1.1. Cardioverter Defibrillator (ICDs)

5.2.1.2. External Defibrillator

5.2.1.3. Wearable Cardioverter Defibrillator (WCDs)

5.2.1.4. Advanced Life Support Units

5.2.1.5. Others

5.2.2.   By End-user

5.2.2.1. Hospitals and Clinics

5.2.2.2. Schools and other Public Spaces

5.2.3.   By Region

5.2.3.1. North America

5.2.3.2. Europe

5.2.3.3. Asia-Pacific (APAC)

5.2.3.4. Latin America (LATAM)

5.2.3.5. Middle-East & Africa (MEA)

6.    North America Cardiology Defibrillators Devices Sales Market Overview

6.1. Market Size and Forecast

6.1.1.   By Value (USD Million), 2017-2027

6.2. Market Share and Forecast

6.2.1.   By Product

6.2.2.   By End-User

6.2.3.   By Country

6.2.3.1. U.S.

6.2.3.2. Canada

7.    Europe Cardiology Defibrillators Devices Sales Market Overview

7.1.     Market Size and Forecast

7.1.1.   By Value (USD Million), 2017-2027)

7.2.     Market Share and Forecast

7.2.1.   By Product

7.2.2.   By End-User

7.2.3.  By Country

7.2.3.1.   Germany

7.2.3.2.   U.K.

7.2.3.3.   France

7.2.3.4.   Italy

7.2.3.5.   Spain

7.2.3.6.   Russia

7.2.3.7.   Netherlands

7.2.3.8.   Rest of Europe

8.    APAC Cardiology Defibrillators Devices Sales Market Overview

8.1.     Market Size and Forecast

8.1.1.   By Value (USD Million), 2017-2027)

8.2.     Market Share and Forecast

8.2.1.   By Product

8.2.2.   By End-User

8.2.3.   By Country

8.2.3.1.   China

8.2.3.2.   India

8.2.3.3.   Japan

8.2.3.4.   South Korea

8.2.3.5.   Rest of APAC

9.    LATAM Cardiology Defibrillators Devices Sales Market Overview

9.1.     Market Size and Forecast

9.1.1.   By Value (USD Million), 2017-2027)

9.2.     Market Share and Forecast

9.2.1.   By Product

9.2.2.   By End-User

9.2.3.   By Country

9.2.3.1.   Mexico

9.2.3.2.   Brazil

9.2.3.3.   Rest of LATAM

10.MEA Cardiology Defibrillators Devices Sales Market Overview

10.1.   Market Size and Forecast

10.1.1.                By Value (USD Million), 2017-2027)

10.2.   Market Share and Forecast

10.2.1.                By Product

10.2.2.                By End-User

10.2.3.                By Country

10.2.3.1.              Saudi Arabia

10.2.3.2.              UAE

10.2.3.3.              South Africa

10.2.3.4.              Rest of Europe

11.Competitive Landscape

11.1.1.                List of Key Producers and Their Offerings

11.1.2.                Market Share / Ranking Analysis (2020)

11.1.3.                Competitive Benchmarking, By Operating Parameters

12.COVID-19 Impact

12.1.             Future Impact

12.2.             Key Developments during COVID-19

12.3.             Impact on Market

12.3.1.                Different Scenario

12.3.2.                Impact on Companies

12.4.             Regional Impact

13.Key Strategic Recommendations

14. Company Profiles (Company Overview, Financial Matrix, Key Product landscape, Key Personnel, Key Competitors, Contact Address, and Strategic Outlook) *

14.1.             ST. Jude Medical, Inc.

14.2.             Heartsine Technologies, Inc.

14.3.             Zoll Medical Corporation 

14.4.             Medical Research Laboratories, Inc.

14.5.             Sorin Group

14.6.             Boston Scientific Corporation

14.7.             Physio-Control, Inc.

14.8.             Laerdal Medical Corporation

14.9.             Cardiac Science Corporation

14.10.          Defibtech

14.11.          Medtronic Physio-Control Corporation

14.12.          Philips Healthcare; Heartstream Division

14.13.          Nihon Kohden Corporation

14.14.          Cardiac Science, Inc. (formerly Survivalink Corp.)

14.15.          Biotronik

14.16.          Stryker

14.17.          LivaNova Plc

14.18.          CU Medical System Inc.

14.19.          Abbott

14.20.          Other prominent players